MCL

Joel Cayou’s goal as a supervisor in Specimen Handling is to support his staff wherever he can in the vital work they do to keep Mayo Clinic Laboratories’ operations running efficiently.

Mayo Clinic recently announced plans to invest in an expansion project to enhance laboratory medicine. The expansion project will support Mayo Clinic Laboratories' goal to provide diagnostics to Mayo Clinic patients throughout the nation and abroad. Health care teams around the world will have access to laboratory testing through Mayo Clinic Laboratories' Test Catalog, and Mayo Clinic patients will have access to testing via their Mayo Clinic health care providers.  

In this test specific episode of the  "Answers From the Lab" podcast, Melissa Snyder, Ph.D., explains how IBDP2, when used after first-line testing has failed, can distinguish between ulcerative colitis and Crohn’s disease.

In this episode of “Lab Medicine Rounds,” Justin Kreuter, M.D., sits down with Mayo Clinic Laboratories’ manager of Outreach and Network Support, Jane Hermansen, to celebrate laboratory successes from the past and look toward the future.

This “Specialty Testing” webinar will discuss the considerations physicians must weigh when evaluating suspected neuropathy patients with special emphasis put on small-fiber neuropathy and the most appropriate laboratory testing related to that phenotype.

Paul Jannetto, Ph.D., describes Mayo Clinic Laboratories' synovial fluid testing for patients with symptoms of failed hip arthroplasty. The Food and Drug Administration recommends testing for elevated chromium and cobalt, which can indicate a malfunctioning metal hip implant. A Mayo Clinic study found that synovial fluid testing for those elements is more sensitive than serum or whole blood testing.

This "Pathways" program provides Anatomic and Clinical Pathology cases that include a history, potential answers, rationale, and relevant references. Cases for April include the following sub-specialties: Bone and Soft Tissue Pathology, Breast Pathology, Cytopathology, Gastroenterology Pathology, Liver Pathology, Neuropathology, and Laboratory Genetics and Genomics.

Ann Moyer, M.D., Ph.D., discusses TPNUQ, Mayo Clinic Laboratories' genotyping test for identifying patients at risk for thiopurine toxicity. Used prior to therapy initiation, our assay evaluates for nuances in both TPMT and NUDT15, which have associations to thiopurine metabolization.

Sophisticated laboratory testing solved a medical riddle and finally got Jori Pearson back on his feet, doing what he loves.

CPT Code updates posted to mayocliniclabs.com during the month of

In this episode of “Lab Medicine Rounds,” Justin Kreuter, M.D., sits down with Reade Quinton, M.D., assistant professor of Laboratory Medicine and Pathology, to discuss Dr. Quinton’s road to becoming a magician and how to use magic in medicine.

Maria Alice Willrich, Ph.D., explains kappa free light chain testing — Mayo Clinic Laboratories' data-driven approach to diagnose multiple sclerosis. The automated assay is more sensitive, cost-effective, and faster than traditional oligoclonal banding, enabling definitive answers for the challenging diagnosis.

Mayo Clinic researchers have developed and validated a new antibody test to diagnose multiple sclerosis (MS). The new test is an automated and cost-effective method compared to other tests used to diagnose MS, according to the research published in Mayo Clinic Proceedings. The test is now available through Mayo Clinic Laboratories.